Company Filing History:
Years Active: 2021
Title: Innovations of Tai-Yin Ke in Neurodegenerative Disorder Treatment
Introduction
Tai-Yin Ke is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders. His innovative approach has led to the development of a unique oral dosage formulation that addresses critical challenges in medication delivery.
Latest Patents
Tai-Yin Ke holds a patent for an "Oral pH independent dosage formulation for treating neurodegenerative disorders." This patent discloses an oral dosage formulation that is suitable for treating neurodegenerative disorders. The formulation contains both sustained-release and immediate-release drugs. The sustained-release drug is memantine, while the immediate-release drug can be donepezil and/or memantine. Notably, the formulation is characterized by a pH-independent dissolution profile of memantine across a pH range from about 1.0 to about 7.0.
Career Highlights
Tai-Yin Ke is associated with Center Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for neurodegenerative conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Some of his coworkers include Meng-Ju Lee and Shu-Hsien Chang, who contribute to the collaborative efforts at Center Laboratories, Inc. Their teamwork enhances the research and development processes within the company.
Conclusion
Tai-Yin Ke's contributions to the field of neurodegenerative disorder treatment through his innovative patent demonstrate his expertise and dedication. His work continues to pave the way for advancements in pharmaceutical formulations.